VOR and 688331.SS Related Headlines

Go Back

Jun 8, 2026 08:31AM Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Jun 8, 2026 08:30AM Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

VOR and 688331.SS Related Press Releases

Go Back

Jun 8, 2026 08:31AM Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Jun 8, 2026 08:30AM Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

VOR and 688331.SS Related SEC Filings

Go Back